Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial.
Autor: | Barnadas, A1 abarnadasm@santpau.cat, Gil, M2, González, S3, Tusquets, I4, Muñoz, M5, Arcusa, A6, Prieto, L7, Margelí-Vila, M8, Moreno, A9, González, S (AUTHOR), Muñoz, M (AUTHOR), Margelí-Vila, M (AUTHOR) |
---|---|
Zdroj: | British Journal of Cancer. 2/10/2009, Vol. 100 Issue 3, p442-449. 8p. 5 Charts, 1 Graph. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |